EUVIMEDEUVIMED entdecken
Crossref

Splenic marginal zone lymphoma with autoimmune hemolytic anemia

Jay Suriar, Mra Aye, Mohamed M Musadiq, Jason S Cabot

Journal of Medicine and Therapeutics · 2018

DOI: 10.15761/jmt.1000123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicine and Therapeutics, 2018. Verfasst von Jay Suriar und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Splenic Marginal Zone Lymphoma (SMZL) is an Unusual, distinct lymphoma characterized by indolent clinical course and prolonged survival, and having some clinical, cellular and immunophenotypical features that differ from other indolent lymphomas.We describe a case of SMZL that presented with autoimmune hemolytic anemia.

Zitieren

APA

Suriar, J., Aye, M., Musadiq, M. M., & Cabot, J. S. (2018). Splenic marginal zone lymphoma with autoimmune hemolytic anemia. Journal of Medicine and Therapeutics. https://doi.org/10.15761/jmt.1000123

Vancouver

Suriar J, Aye M, Musadiq MM, Cabot JS. Splenic marginal zone lymphoma with autoimmune hemolytic anemia. Journal of Medicine and Therapeutics. 2018. doi:10.15761/jmt.1000123

BibTeX
@article{Suriar2018,
  author = {Suriar, Jay and Aye, Mra and Musadiq, Mohamed M and Cabot, Jason S},
  title = {Splenic marginal zone lymphoma with autoimmune hemolytic anemia},
  journal = {Journal of Medicine and Therapeutics},
  year = {2018},
  doi = {10.15761/jmt.1000123}
}
Kostenlos starten →